Alkermes (company)
Top View
- United States District Court for the District of Columbia
- ALKERMES PUBLIC LIMITED COMPANY Directors’ Report and Consolidated Financial Statements for the Nine Months Ended December 31, 2013 ALKERMES PLC Table of Contents
- Astellas Research Institute of America LLC: Employee (Self) Adinoff, Bryon: Journal Editor: Board Member (Self)
- Signatory Companies
- Neoadjuvant Therapy for Melanoma: a U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop a C Kristen L
- 2017 Regional Chain Conference Strategic Partners Profiles FLOOR PLAN
- 2021 Jp Morgan Healthcare Conference: Preview
- Moderna 2021 Proxy Statement
- Jazz Pharmaceuticals Plc Proxy Statement 2017 Annual Report
- WDD License # Expiration Effective License Holder Name
- Alkermes Announces Approval in Germany for Risperdal Consta; First Atypical Antipsychotic to Be Available As Long-Acting Injection
- United States District Court for the District of Columbia
- UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C
- 1 Alkermes Public Limited Company Directors' Report
- Alkermes Announces Approval in United Kingdom for Risperdal Consta
- Smaller Companies Win in Most Valuable Race
- Member Since (Alphabetical Order) 1976 3M Medical Solutions Division 2019 Electrocore, Inc
- Alkermes Appoints Craig Hopkinson, M.D., As Chief Medical Officer, and Senior Vice President, Clinical Development and Medical Affairs